Literature DB >> 10883001

Mitochondrial myopathy and familial thiamine deficiency.

Y Sato1, M Nakagawa, I Higuchi, M Osame, E Naito, K Oizumi.   

Abstract

We studied two siblings with a mitochondrial myopathy, familial thiamine deficiency, and an A3243G mutation of the mitochondrial DNA (mtDNA). The elder brother (patient 1, now 36 years old) developed myopathy and beriberi heart at 20 years of age. Thiamine therapy resolved the cardiac symptoms and hyperpyruvicemia and improved the myopathy. The younger brother presented aged 19 years with a myopathy (patient 2, now 35 years old). Thiamine deficiency was present in the siblings and parents, and ragged-red fibers (RRFs) were noted in muscle biopsies from the siblings. Analysis 17 years later demonstrated thiamine malabsorption and an A3243G mutation of the mtDNA in both siblings and their mother, progressive myopathy, and an increased number of RRFs and elevated serum CKMB activity in patient 1. Thiamine treatment decreased the serum concentrations of lactate and pyruvate in patient 2, but not patient 1. The role of thiamine in mitochondrial dysfunction caused by an electron transfer disorder in the setting of A3243G mtDNA mutation is discussed. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10883001     DOI: 10.1002/1097-4598(200007)23:7<1069::aid-mus9>3.0.co;2-0

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

Review 1.  Therapies for mitochondrial diseases and current clinical trials.

Authors:  Ayman W El-Hattab; Ana Maria Zarante; Mohammed Almannai; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2017-09-18       Impact factor: 4.797

Review 2.  Advances in drug therapy for mitochondrial diseases.

Authors:  Lufei Zhang; Zhaoyong Zhang; Aisha Khan; Hui Zheng; Chao Yuan; Haishan Jiang
Journal:  Ann Transl Med       Date:  2020-01

3.  Mitochondrial Disease.

Authors:  Roser Pons; Darryl C. De Vivo
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

Review 4.  Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs.

Authors:  Vincenzo Tragni; Guido Primiano; Albina Tummolo; Lucas Cafferati Beltrame; Gianluigi La Piana; Maria Noemi Sgobba; Maria Maddalena Cavalluzzi; Giulia Paterno; Ruggiero Gorgoglione; Mariateresa Volpicella; Lorenzo Guerra; Domenico Marzulli; Serenella Servidei; Anna De Grassi; Giuseppe Petrosillo; Giovanni Lentini; Ciro Leonardo Pierri
Journal:  Molecules       Date:  2022-05-29       Impact factor: 4.927

5.  Wernicke-Korsakoff syndrome associated with mtDNA disease.

Authors:  Idris Janos Jimoh; Barbara Sebe; Peter Balicza; Mariann Fedor; Ilona Pataky; Gabor Rudas; Aniko Gal; Gabriella Inczedy-Farkas; Gyorgy Nemeth; Maria Judit Molnar
Journal:  Ther Adv Neurol Disord       Date:  2020-07-30       Impact factor: 6.570

6.  Current progress in the therapeutic options for mitochondrial disorders.

Authors:  E Koňaříková; A Marković; Z Korandová; J Houštěk; T Mráček
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

7.  Can long-term thiamine treatment improve the clinical outcomes of myotonic dystrophy type 1?

Authors:  Antonio Costantini; Erika Trevi; Maria Immacolata Pala; Roberto Fancellu
Journal:  Neural Regen Res       Date:  2016-09       Impact factor: 5.135

Review 8.  Nutrition, Bioenergetics, and Metabolic Syndrome.

Authors:  Francesc Josep García-García; Anna Monistrol-Mula; Francesc Cardellach; Glòria Garrabou
Journal:  Nutrients       Date:  2020-09-11       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.